Hi all MSB holders,
I've been following recent HC:MSB speculation about what's actually going on, and concern at the SP. Although it's completely understandable I don't think we can get too far ahead of ourselves just at the moment. There's far too much happening in March, or just about to happen, as I see it.
So while we're waiting, here's what I consider to be a technically credentialled, well-balanced, & independent op-ed article to help put a smile on your dial. It's interesting that we're being scrutinised so closely from the other side of the planet right now.
Enjoy:
Link here: https://www.pharmaceutical-technology.com/news/mesoblast-eyes-accelerated-approval-filing-for-heart-failure-cell-therapy/?cf-view
Hope that gave you something to cheer up about. And the shorts were still down at 2.64% on 12 March, according to ASIC. How about that.
Don't be too worried about BioCardia. With a market cap of US$8.43m, they may have more on their plate to be concerned about than MSB does.
Cheers
GLTA(LT)H
Cell Therapy News/Articles, page-17530
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.025(2.23%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.04 | $14.57M | 13.49M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21024 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 241 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |